Search results
William Sellers is a core institute member of the Broad Institute of MIT and Harvard and the director of its Cancer Program. He is a cancer scientist and drug discovery expert who has led major genomic and therapeutic advances in lung, prostate and melanoma cancers.
William Sellers is a cancer researcher and professor at Harvard Medical School and the Broad Institute. He studies cancer dependent genes, genetic alterations, functional perturbations and therapeutic discovery in cancer.
William Sellers is a professor of medicine and a cancer researcher at the Broad Institute of MIT and Harvard. He studies cancer dependent genes and develops novel therapeutics to target them.
People also ask
Who is William Sellers?
Who owns William Sellers & Co?
Who is Thomas Sellers?
What did William Sellers do for a living?
2000. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. ME McMenamin, P Soung, S Perera, I Kaplan, M Loda, WR Sellers. Cancer research 59 (17), 4291-4296. , 1999. 921. 1999. Articles 1–20. Core Institute Member, The Broad Institute - Cited by 97,065 ...
Systematic elucidation of cancer dependencies. Leveraging the CCLE, within Novartis, Bill Sellers led the efforts to annotate the gene-level functional requirements for 7,700 genes targeted by an average of 20 shRNA per gene in 390+ cell lines.
Nov 22, 2016 · William Sellers is a cancer genomics and therapeutics expert who returned to the Broad Institute, Dana-Farber Cancer Institute, and Harvard Medical School in 2017. He has a long history of discovering and developing drugs for various cancers, such as lung, prostate, and melanoma.
William SELLERS | Broad Institute of MIT and Harvard, MA | Sellers Lab | Research profile. About. 351. Publications. 60,551. Reads. 77,282. Citations. Introduction. Skills and Expertise....
